Finzati - Logo
BETRF logo

BetterLife Pharma Inc.

BETRF • Biotechnology
$0.15
▼ -0.00 (-2.67%)
Current price
EarningsLatest report: Jul 31, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$24.22M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.03Weak profitability
Financial data as of: Jul 31, 2026, 12:00 AM UTCLast earnings update: Jul 31, 2026, 12:00 AM UTCLast profile update: Oct 1, 2026, 12:08 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.15
Change-2.67%
Shares Out162.32M
Market Cap$24.22M
52W Range0.03 - 0.33
Beta0.22
P/E-3.12
P/S0.00
P/B-0.48
P/FCF-7.46
EV/Sales0.00
EV/EBITDA-4.66

Investment DNA

How strong this company looks for long-term investors

33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Weak liquidity · 0.03Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 9/1/2010
Industry: Biotechnology
P/B i: -0.48
Debt / Equity i: -0.09
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score4 / 20
Debt / Equity: -0.09
Current Ratio: 0.03
Quick Ratio: 0.03
Status: HighRisk

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Doroudian Ahmad
Transaction: 01/31/2014
OPTION
Change
0
Price
Not reported
Filing
03/10/2015
Type
OPTION
Doroudian Ahmad
Transaction: 09/24/2013
BUY
Change
+35,000,000
Price
Not reported
Filing
03/10/2015
Type
BUY
Doroudian Ahmad
Transaction: 01/31/2011
OPTION
Change
0
Price
Not reported
Filing
03/10/2015
Type
OPTION